NCI Scientists Receive 2008 HHS Awards
On January 6, four NCI scientists from the Center for Cancer Research (CCR) were honored by the Department of Health and Human Services with 2008 Departmental Awards.
Dr. Ira Pastan, of the Laboratory of Molecular Biology, was presented the Secretary’s Award for Meritorious Service for his outstanding contributions to the development of immunotoxins against cancer. Drs. Douglas Lowy and John Schiller received the Hubert H. Humphrey Award for Service to America, for their contributions to the development of the first HPV vaccines. And Dr. Robert Wiltrout received the Career Achievement Award for exceptional leadership of CCR and consistently outstanding research in the immunology and cancer fields.
NCI Holds Annual Intramural Scientific Retreat
On January 8, NCI’s intramural scientific investigators came together to share their research at the Annual Intramural Scientific Retreat. The retreat was an opportunity for investigators to interact with colleagues from different disciplines and to learn about the work being done in labs across the institute.
Over the course of the day, three award lectures were presented. Dr. Ira Pastan delivered the 5th Annual Alan S. Rabson Award Lecture for Intramural Research. Dr. Carol Prives of Columbia University presented the 8th Annual Rosalind E. Franklin Award Lecture for Women in Cancer Research, and Dr. Brian Druker, director of the Knight Cancer Institute at Oregon Health and Science University, spoke about translational research and his work developing imatinib (Gleevec) during the 13th Annual Alfred G. Knudson Award Lecture in Cancer Genetics.
Finally, a number of NCI scientists received NCI Director’s Intramural Innovation Awards, which are designed to support the development of highly innovative approaches and technologies aimed at significant cancer-related problems.
New Issue of CCR Connections Released
NCI’s Center for Cancer Research (CCR) recently released a new issue of their news magazine, CCR Connections. To view the Web version of Volume 2, Issue 2, please visit: http://home.ccr.cancer.gov/connections/index.asp.
In the latest issue, readers will find information on recent journal articles and staff awards, as well as a conversation with CCR’s new chief of the Medical Oncology Branch; features on targeted imaging technologies, the DNA of drug discovery, and ovarian cancer; and a commentary by former CCR investigator Dr. Bruce Johnson.
CCR Connections is published biannually. Send a request for a print or online subscription to email@example.com.